Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Initial cognitive changes in Parkinson's disease.

Daniel Weintraub1,2, Alexander I Tröster3, Connie Marras4

  • 1Departments of Psychiatry and Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Movement Disorders : Official Journal of the Movement Disorder Society
|March 16, 2018
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Essential genetic testing in movement disorders - results from a Delphi study.

Parkinsonism & related disorders·2026
Same author

Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMI.

Annals of neurology·2026
Same author

Neuropsychiatric Symptom Clusters and Their Association With Brain Structure in Alzheimer Disease.

The Journal of clinical psychiatry·2026
Same author

Reply to: "Revisiting Nomenclature in Movement Disorders: The Boundaries Between Pragmatism, Academicism, and Practical Applicability".

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

MDSGene Systematic Review of Common Forms of Dominant Hereditary Spastic Paraplegia: Novel Insights.

Movement disorders clinical practice·2026
Same author

Defining Quality of Life: The Perspective of People Living with Parkinson's Disease.

Movement disorders clinical practice·2026
Same journal

Key Interventions in Friedreich's Ataxia and Their Impact on Patient Outcomes: A Systematic Review.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Comment on: "Bilateral Deep Brain Stimulation of the Subthalamic Nucleus or Globus Pallidus Internus Improves Gait Impairment in Parkinson's Disease".

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

A Phase 1 Study of Convection-Enhanced Delivery of Intraputaminal AAV2-GDNF in Advanced Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Reply to Comment on: "Bilateral Deep Brain Stimulation of the Subthalamic Nucleus or Globus Pallidus Internus Improves Gait Impairment in Parkinson's Disease".

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Gene Therapy for Amino Acid Decarboxylase Deficiency: Clinical and Imaging Outcomes in a French Cohort.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Alzheimer's Disease Cerebrospinal Fluid Biomarkers Predict Survival in Progressive Supranuclear Palsy.

Movement disorders : official journal of the Movement Disorder Society·2026
See all related articles
This summary is machine-generated.

Researchers are shifting focus to early cognitive impairment in Parkinson's disease (PD) to enable earlier therapeutic interventions. This study examines challenges and findings in identifying and assessing mild cognitive impairment in PD.

Area of Science:

  • Neuroscience
  • Neurology
  • Cognitive Science

Background:

  • Neurodegenerative diseases, such as Parkinson's disease (PD), are increasingly recognized to involve cognitive impairment beyond the dementia stage.
  • A paradigm shift is occurring, moving the focus from late-stage dementia to earlier stages like mild cognitive impairment (MCI) in PD.
  • Early detection of MCI in PD is crucial for timely therapeutic interventions, potentially even presymptomatically, to improve long-term outcomes.

Purpose of the Study:

  • To review key findings and challenges in the study of early cognitive decline in Parkinson's disease.
  • To provide an in-depth examination of neuropsychological testing methods for detecting cognitive impairment in PD.
  • To summarize current epidemiological research on mild cognitive impairment in PD and offer expert recommendations for assessment.
Keywords:
Parkinson's diseasedementiamild cognitive impairmentneuropsychological testing

Related Experiment Videos

Main Methods:

  • Review of current literature on cognitive impairment in Parkinson's disease.
  • Detailed examination of neuropsychological testing batteries used for early cognitive decline assessment.
  • Analysis of epidemiological data concerning mild cognitive impairment in PD.
  • Compilation of expert recommendations for the assessment of cognitive impairment in early and prodromal PD.

Main Results:

  • The focus in Parkinson's disease research is shifting towards identifying and characterizing mild cognitive impairment (MCI) in its earlier and prodromal stages.
  • Neuropsychological testing presents both opportunities and challenges in accurately assessing subtle cognitive deficits in early PD.
  • Existing epidemiological research provides a foundation for understanding the prevalence and progression of MCI in PD, highlighting the need for standardized assessment.

Conclusions:

  • Early identification of cognitive impairment, including MCI, in Parkinson's disease is critical for advancing therapeutic strategies.
  • Standardized and sensitive neuropsychological assessments are essential for accurate diagnosis and monitoring of cognitive changes in PD.
  • Further research and expert consensus are needed to refine the assessment and management of cognitive decline in the early stages of PD.